You are here: Industry Insights > COVID-19

News List

73,000 Scientists collaborate over new COVID-19 Data Portal to speed up vaccine development worldpharmanews
August 27, 2020
More than 73,000 users collaborate on new online platform set up by the European Open Science Cloud Initiative, where scientists share COVID-19 data and accelerate our understanding of the virus to help develop treatments and vaccines quicker.
AstraZeneca doses first patients in COVID-19 therapy trial europeanpharmaceuticalreview
August 27, 2020
The Phase I trial will assess the safety and pharmacokinetics of the AZD7442 monoclonal antibody combination in 48 healthy participants.
Q BioMed, Mannin Announce GMP Production of COVID-19 Therapeutic for Clinical Trial americanpharmaceuticalreview
August 27, 2020
Q BioMed announced with its technology partner, Mannin Research, a GMP production contract has been initiated for MAN-19, a clinical grade therapeutic intended to treat complications caused by COVID-19.
Intas gets DCGI nod for clinical trials of hyperimmune globulin for COVID-19 treatment expresspharma
August 27, 2020
It can be an important therapeutic option that can potentially help combat the disease until a vaccine is available, states the company.
Is Avoidable Experiment Expenditure Draining Billions from COVID-19 Research? fiercepharma
August 26, 2020
The rise of COVID-19 represents an unprecedented situation for pharma. With the scramble to find a vaccine, R&D productivity is more important than ever, which makes it especially concerning that pharma still struggles with a widely recognized productivit
COVID-19 vaccine grown in insect cells approved for clinical trials chinadaily
August 26, 2020
A COVID-19 vaccine grown in insect cells has been approved by the National Medical Products Administration for clinical trials on Aug 21, Science Daily reported.
COVID-19 vaccine candidate produced from insect cells to enter human trials chinadaily
August 26, 2020
China has approved human trials for a new COVID-19 vaccine candidate, which was produced by the use of insect cells.
Hercules' AhR Inhibitor HP163 Blocks Viral Replication in Zika Infection and Potentially in Covid-19 b3cnewswire
August 26, 2020
A recent publication in Nature Neuroscience reported that Hercules’ AhR inhibitor HP163 reduces viral replication in animals infected with Zika-virus and reduced microencephaly.
FDA issues emergency use authorisation for COVID-19 convalescent plasma europeanpharmaceuticalreview
August 26, 2020
The emergency use authorisation (EUA) allows the distribution and administration of COVID-19 convalescent plasma to hospitalised patients in the US.
AGGRASTAT? shows promise for treating COVID-19 thrombotic complications europeanpharmaceuticalreview
August 26, 2020
According to Medicure, AGGRASTAT (tirofiban hydrochloride) has shown promise for preventing and treating thrombotic complications due to COVID-19.